Evidence map›Paper›PMID 40951352›Full record

ArticleFrontiers in oncology2025

A case report and literature review on positive outcomes achieved through radiotherapy in a patient with composite hemangioendothelioma.

Fei Zhang, Cha Luo, Ying Zeng, Zhonglian Wang, Hongting Jiang, Qing Ye, Wei Jian, Jing Zhang, Qiaofen Fu

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fei ZhangDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Cha LuoDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Ying ZengDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Zhonglian WangDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Hongting JiangDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Qing YeDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Wei JianDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Jing ZhangDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Qiaofen FuDepartment of Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Composite hemangioendothelioma (CHE) is a rare borderline vascular neoplasm, typically characterized by a heterogeneous composition of benign, intermediate, and malignant vascular elements. Metastasis occurs occasionally, yet local recurrence remains relatively common. CHE frequently manifest in the deep dermis and subcutaneous soft tissues of the distal limbs, and are rarely observed in bone or vertebral column. We present a case that originally occurred in the lumbar spine. Case presentation: A 75-year-old male patient presented with progressively worsening pain in the lumbar and gluteal regions, accompanied by impaired mobility. Lumbar spine MRI and PET-CT imaging revealed abnormal signals in the left side of the L5 vertebral body and the left pedicle, indicative of potentially aggressive pathological changes. Pathological biopsy under general anesthesia confirmed a diagnosis of CHE. Given the impossibility of completely resecting the lesion, the patient underwent radiation therapy. After a course of radiotherapy (60Gy/30 fractions), the patient was discharged from the hospital. The patient has been followed up for a period of 20 months with no evidence of recurrence. Conclusion: CHE refers to a rare type of tumor that rarely involves the spine. We present a case of CHE occurring in the L5 vertebral body. Given the lack of definitive indications for surgical intervention, radiation therapy was administered, resulting in highly satisfactory therapeutic outcomes and an excellent prognosis.

Indexed as

CHEcomposite hemangioendotheliomaradiationradiation therapyvascular neoplasm

Identifiers

PMID40951352
PMCPMC12425709

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.